Biotechnology has revolutionized drug development, offering innovative therapies like monoclonal antibodies and recombinant proteins. This book explores key concepts in pharmaceutical biotechnology, including genetic engineering, fermentation technology, and biopharmaceutical production. It discusses the development of vaccines, biosimilars, and gene therapies, alongside quality control and regulatory considerations. Practical applications in diagnostics and personalized medicine are highlighted. Designed for pharmacy and biotechnology students, this text links molecular biology with clinical and commercial outcomes in modern healthcare.
Finn Wallace is a molecular biologist turned pharmaceutical biotechnologist, whose expertise lies in recombinant protein production, monoclonal antibody development, and gene-based therapies. He has collaborated with leading biotech firms on developing biologics for immunological and oncological applications. Finn’s academic work includes peer-reviewed papers on vector design and expression systems, and he regularly contributes to biotech innovation summits. His research emphasizes scalable solutions for emerging therapies and biosimilar production.